Basilea Pharmaceutica Ag
(OTC) BPMUF
Basilea Pharmaceutica Ag Financials at a Glance
Market Cap
$872.84M
Revenue (TTM)
$441.00M
Net Income (TTM)
$117.80M
EPS (TTM)
$3.67
P/E Ratio
17.82
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Price
$71.00
Volume
100
Open
$71.00
Price
$71.00
Volume
100
Open
$71.00
Previous Close
$71.00
Daily Range
$71.00 - $71.00
52-Week Range
$47.50 - $74.00
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Price
$71.00
Volume
100
Open
$71.00
Previous Close
$71.00
Daily Range
$71.00 - $71.00
52-Week Range
$47.50 - $74.00
BPMUF News
BPMUF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Basilea Pharmaceutica Ag
Industry
Biotechnology
Sector
Health CareEmployees
189
CEO
David Veitch
Website
www.basilea.comHeadquarters
Allschwil, 4058, CH
BPMUF Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
22%
Net Income Margin
18%
Return on Equity
39%
Return on Capital
17%
Return on Assets
11%
Earnings Yield
5.61%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$872.84M
Shares Outstanding
12.29M
Volume
100
Short Interest
0.00%
Avg. Volume
5.683
Financials (TTM)
Gross Profit
$193.19M
Operating Income
$51.62M
EBITDA
$51.62M
Operating Cash Flow
$62.12M
Capital Expenditure
$2.62M
Free Cash Flow
$59.50M
Cash & ST Invst.
$162.41M
Total Debt
$100.98M
Basilea Pharmaceutica Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$128.50M
+76.7%
Gross Profit
$113.42M
+102.8%
Gross Margin
88.27%
N/A
Market Cap
$872.84M
N/A
Market Cap/Employee
$5.32M
N/A
Employees
164
N/A
Net Income
$24.41M
+214.1%
EBITDA
$27.58M
+776.8%
Quarterly Fundamentals
Net Cash
$61.43M
+189.4%
Accounts Receivable
$63.31M
+127.0%
Inventory
$21.57M
-18.3%
Long Term Debt
$98.92M
-11.0%
Short Term Debt
$2.06M
-88.2%
Return on Assets
11.45%
N/A
Return on Invested Capital
17.00%
N/A
Free Cash Flow
$36.75M
+544.7%
Operating Cash Flow
$39.05M
+612.6%